The EU hopes to eradicate the risk of gender discrimination when insurers assess premiums with its Equal Treatment Directive. Peter Carvill explores how male and female claims compare
Of all the wonderful things the UK has to thank Europe for - Joseph Conrad, Jean-Paul Belmondo, the Englightenment and croissants - perhaps the most significant to the protection industry is the European Union's recent Equal Treatment Directive. It means insurers can no longer assess premiums on the grounds of gender unless it can be proven that being male or female is a decisive factor in the risk being carried by the provider. For example, it is inarguable that men are less susceptible to breast cancer than women - current figures show male breast cancer accounts for just 1% of cases ...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes